Skip to main content
Fig. 1 | Human Genomics

Fig. 1

From: A pan-cancer analysis of the oncogenic and immunological roles of RGS5 in clear cell renal cell carcinomas based on in vitro experiment validation

Fig. 1

RGS5 expression and prognosis analysis in human cancers. A Pan-cancer analysis of RGS5 for differential expression between tumor and normal tissues in TCGA cohort. B Pan-cancer analysis of RGS5 for differential expression between tumor and normal tissues in GEO cohort. C Pan-cancer analysis of RGS5 for overall survival (OS). D Pan-cancer analysis of RGS5 for disease-specific survival (DSS). E Pan-cancer analysis of RGS5 for disease-free interval (DFI). F Pan-cancer analysis of RGS5 for progression-free interval (PFI). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001

Back to article page

Human Genomics

ISSN: 1479-7364